| Literature DB >> 34055400 |
Jean-Philippe Rozon1,2, Guillaume Lavertu2, Mélanie Hébert2, Eunice You2, Serge Bourgault2, Mathieu Caissie2, Eric Tourville2, Ali Dirani2.
Abstract
PURPOSE: To identify predictive factors for visual outcomes of patients presenting with a posterior segment intraocular foreign body (IOFB).Entities:
Year: 2021 PMID: 34055400 PMCID: PMC8149226 DOI: 10.1155/2021/9990290
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Clinical characteristics of 54 study participants.
| Clinical characteristics | Mean ± SD or |
|---|---|
| IOFB size, mm | 5.31 ± 4.62 |
| IOFB nature | |
| Metallic | 48 (89%) |
| Glass | 3 (6%) |
| Fireworks | 1 (2%) |
| Organic | 1 (2%) |
| Unknown | 1 (2%) |
|
| |
| IOFB entry site | |
| Cornea | 30 (56%) |
| Sclera | 15 (28%) |
| Corneoscleral | 8 (15%) |
| Unknown | 1 (2%) |
|
| |
| IOFB location | |
| Retina | 31 (57%) |
| Vitreous | 19 (35%) |
| Orbit | 2 (4%) |
| Optic nerve | 1 (2%) |
| Unknown | 1 (2%) |
|
| |
| Secondary clinical features | |
| Cataract | 39 (72%) |
| Vitreous hemorrhage | 28 (52%) |
| Hyphema | 17 (31%) |
| Retinal detachment | 16 (30%) |
| Retinal tears | 8 (15%) |
| Iris damage | 6 (11%) |
| Choroid detachment | 3 (6%) |
| Endophthalmitis | 1 (2%) |
IOFB, intraocular foreign body; SD, standard deviation.
Figure 1Histogram illustrating number of intraocular foreign bodies per year during the study period.
Initial and final VA.
| VA | Initial VA | Final VA |
|---|---|---|
| NLP, LP or HM | 24 (44%) | 10 (19%) |
| CF to 6/60 | 8 (15%) | 16 (30%) |
| 6/45 to 6/21 | 4 (7%) | 1 (2%) |
| 6/18 to 6/12 | 10 (19%) | 9 (17%) |
| 6/9 to 6/6 | 8 (15%) | 18 (33%) |
CF, counting fingers; HM, hand motion; LP, light perception; NLP, no light perception; VA, visual acuity.
Baseline characteristics of 54 patients with intraocular foreign body by final visual acuity.
| Characteristics | Final visual outcome |
| |
|---|---|---|---|
| Good >50 letters ETDRS | Poor ≤50 letters ETDRS | ||
| Mean ± SD or | |||
| Male sex | 28 (93%) | 22 (92%) | 0.82 |
| Age | 38.5 ± 12.5 | 43.5 ± 12.1 | 0.15 |
| Baseline VA | 57.9 ± 30.9 | 12.5 ± 24.3 |
|
| Delay | 20.0 ± 66.7 | 9.8 ± 39.3 | 0.47 |
| IOFB | |||
| Metallic nature | 28 (93%) | 19 (83%) | 0.22 |
| Size | 2.8 ± 1.7 | 7.5 ± 5.2 |
|
| Localization | |||
| Vitreous | 13 (43%) | 6 (25%) | 0.16 |
| Retina | 17 (57%) | 14 (58%) | 0.90 |
| Entry site | |||
| Cornea | 17 (57%) | 13 (57%) | 0.99 |
| Corneoscleral | 3 (10%) | 5 (22%) | 0.24 |
| Sclera | 10 (33%) | 5 (22%) | 0.35 |
| Number of additional diagnoses | 1.7 ± 1.0 | 3.5 ± 1.4 |
|
| Vitreous hemorrhage | 10 (33%) | 18 (75%) |
|
| Cataract | 20 (67%) | 19 (79%) | 0.31 |
| Retinal detachment | 6 (20%) | 10 (42%) | 0.08 |
| Retinal tear | 3 (10%) | 5 (21%) | 0.27 |
| Hyphema | 3 (10%) | 14 (58%) | < |
| Iris damage | 1 (3%) | 5 (21%) |
|
| Choroid detachment | 1 (3%) | 2 (8%) | 0.43 |
| Endophthalmitis | 0 (0%) | 1 (4%) | 0.26 |
| Interventions | |||
| Anterior chamber extraction | 0 (0%) | 5 (21%) |
|
| Pars plana extraction | 30 (100%) | 24 (100%) | 1.00 |
| Scleral buckle | 8 (27%) | 11 (46%) | 0.14 |
| Graft | 2 (7%) | 3 (13%) | 0.46 |
| First intention IOL | 8 (27%) | 3 (13%) |
|
| Reoperation | 4 (13%) | 10 (42%) |
|
| Tamponade | |||
| Air | 17 (57%) | 6 (25%) |
|
| SF6 | 11 (37%) | 4 (17%) | 0.10 |
| C3F8 | 0 (0%) | 7 (29%) |
|
| Silicone | 2 (7%) | 7 (29%) |
|
| Postoperative VA | 79.6 ± 7.0 | 13.1 ± 14.9 | < |
Bolded figures = statistically significant results at the 0.05 level. Abbreviations: ETDRS, Early Treatment Diabetic Retinopathy Study; IOFB, intraocular foreign body; SD, standard deviation; VA, visual acuity.
Multiple logistic regression for predictive factors of worse final visual acuity following intraocular foreign body extraction in 54 patients.
| Characteristics | OR (95% CI); |
|---|---|
| Age, years | 1.00 (0.93, 1.07); 0.97 |
| Baseline VA, ETDRS | 0.97 (0.94, 0.99); |
| Number of additional diagnoses | 2.95 (1.40, 7.56); |
Bolded figures = statistically significant results at the 0.05 level. Abbreviations: CI, confidence interval; ETDRS, Early Treatment Diabetic Retinopathy Study; OR, odds ratio; VA, visual acuity.